Leadership & Pay ·
Spero Therapeutics COO Timothy Keutzer to retire effective December 31
SPROSpero Therapeutics, Inc.
Spero Therapeutics announced that Chief Operating Officer Timothy Keutzer will retire on December 31, 2026, following 11 years of service. The company expects to engage Mr. Keutzer as a consultant until approximately February 28, 2027, at an hourly rate, to support the transition. Spero Therapeutics operates in the biopharmaceutical industry.